Related Experiment Video
Updated: Feb 7, 2026

Characterization of MLKL-mediated Plasma Membrane Rupture in Necroptosis
Published on: August 7, 2018
Caspase-2 is a negative regulator of necroptosis
Alexey V Zamaraev1, Gelina S Kopeina1, Jörn H Buchbinder2
1Faculty of Medicine, MV Lomonosov Moscow State University, 119991 Moscow, Russia.
Abstract:
The role of caspase-2 in cell death regulation remains largely unknown. In this study we have analyzed the involvement of caspase-2 in RIPK1-regulated necrosis (necroptosis) in human ovarian carcinoma cells. We show that these cells undergo necroptosis upon treatment with the DNA damaging drug cisplatin in combination with the pan-caspase inhibitor zVAD-fmk. Downregulation of caspase-2 leads to an increase of necroptosis in CAOV-4 cells. Interestingly, an association of caspase-2 to the necrosome complex was not detected. Importantly, downregulation of caspase-2 with shRNA or CRISPR/Cas9 system led to an enhanced phosphorylation of RIPK1 and MLKL. Taken together, our data strongly indicate that caspase-2 negatively regulates necroptotic cell death, which might play an important role in further therapeutic applications.
Insights
Caspase-2 negatively regulates necroptosis, a form of cell death. Reducing caspase-2 levels increases necroptosis, suggesting its potential role in cancer therapy.
Area of Science:
- Cell Biology
- Molecular Oncology
- Immunology
Background:
- The precise role of caspase-2 in regulating cell death pathways is not fully understood.
- Necroptosis, a programmed form of necrosis, is implicated in various diseases, including cancer.
Purpose of the Study:
- To investigate the involvement of caspase-2 in RIPK1-regulated necroptosis in human ovarian carcinoma cells.
- To elucidate the regulatory function of caspase-2 in the necroptotic pathway.
Main Methods:
- Human ovarian carcinoma cells (CAOV-4) were treated with cisplatin and a pan-caspase inhibitor (zVAD-fmk) to induce necroptosis.
- Caspase-2 was downregulated using shRNA and CRISPR/Cas9 gene-editing systems.
- Association of caspase-2 with the necrosome complex was assessed.
- Phosphorylation levels of RIPK1 and MLKL were analyzed.
Main Results:
- Cisplatin and zVAD-fmk treatment induced necroptosis in CAOV-4 cells.
- Downregulation of caspase-2 significantly increased the rate of necroptosis.
- Caspase-2 did not associate with the necrosome complex.
- Reduced caspase-2 levels led to enhanced phosphorylation of RIPK1 and MLKL, key mediators of necroptosis.
Conclusions:
- Caspase-2 acts as a negative regulator of necroptotic cell death.
- The findings suggest a novel role for caspase-2 in controlling cell death, with potential implications for therapeutic strategies in ovarian cancer and other malignancies.
Related Concept Videos
Negative Regulator Molecules
Caspases
Master Transcription Regulators
Positive, Negative, and Zero Work
Epigenetic Regulation
GTPases and their Regulation
Large G-proteins,...

